Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder

por Kotzalidis, Georgios D., Lombardozzi, Ginevra, Matrone, Marta, Amici, Emanuela, Perrini, Filippo, Cuomo, Ilaria, De Filippis, Sergio
Publicado 2021

Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, sub...

por Cuomo, Ilaria, Kotzalidis, Georgios D, de Persis, Simone, Piacentino, Daria, Perrini, Filippo, Amici, Emanuela, De Filippis, Sergio
Publicado 2018

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis

por Giordano, Gloria, Tomassini, Lorenzo, Cuomo, Ilaria, Amici, Emanuela, Perrini, Filippo, Callovini, Gemma, Carannante, Alfonso, Kotzalidis, Georgios D., De Filippis, Sergio
Publicado 2020

Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma

por De Filippis, Sergio, Lombardozzi, Ginevra, Matrone, Marta, Amici, Emanuela, Trovini, Giada, Perrini, Filippo, Di Giovanni, Alessandro, Giovanetti, Valeria, Kotzalidis, Georgios D.
Publicado 2022

Burnout and Psychological Vulnerability in First Responders: Monitoring Depersonalization and Phobic Anxiety during the COVID-19 Pandemic

por Benincasa, Veronica, Passannante, Maria, Perrini, Filippo, Carpinelli, Luna, Moccia, Giuseppina, Marinaci, Tiziana, Capunzo, Mario, Pironti, Concetta, Genovese, Armando, Savarese, Giulia, De Caro, Francesco, Motta, Oriana
Publicado 2022